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Type 1 diabetes mellitus (T1D) is associated with decreased bone mineral density, a deficit in bone structure, and subsequently an
increased risk of fragility fracture. These clinical observations, paralleled by animal models of T1D, suggest that the insulinopenia
ofT1Dhasadeleteriouseffectonbone.Tofurtherexaminetheactionofinsulinsignalingonbonedevelopment,wegeneratedmice
with an osteoprogenitor-selective (osterix-Cre) ablation of the insulin receptor (IR), designated OIRKO. OIRKO mice exhibited an
80% decrease in IR in osteoblasts. Prenatal elimination of IR did not affect fetal survival or gross morphology. However, loss of IR
in mouse osteoblasts resulted in a postnatal growth-constricted phenotype. By 10–12 weeks of age, femurs of OIRKO mice were
more slender, with a thinner diaphyseal cortex and, consequently, a decrease in whole bone strength when subjected to bending.
In male mice alone, decreased metaphyseal trabecular bone, with thinner and more rodlike trabeculae, was also observed. OIRKO
mice did not, however, exhibit abnormal glucose tolerance. The skeletal phenotype of the OIRKO mouse appeared more severe
than that of previously reported bone-specific IR knockdown models, and confirms that insulin receptor expression in osteoblasts
is critically important for proper bone development and maintenance of structural integrity.
1. Introduction
Skeletalhealthiscompromisedinpersonswithtype1diabetes
mellitus (T1D), as characterized by decreased bone mineral
density (BMD), a deficit in bone structure, and subsequently
an increased risk of fragility fractures [1, 2]. Indeed, T1D
h a sb e e nl i s t e da m o n gt h et o p1 0f a c t o r sa s s o c i a t e dw i t ht h e
highest risk of fracture [3]. Because T1D is characterized
in humans and rodents as a state of insulin deficiency due
to destruction of pancreatic beta cells (either autoimmune-
mediated or chemically induced), a role for insulinopenia in
the pathogenesis of osteoporosis and increased fracture risk,
nowcategorizedasdiabeticbonedisease,hasbeenpostulated
[4].
Insulinhasbeendemonstratedinvitroandinvivotobean
osteogenic hormone. Primary osteoblasts and osteoblast-like
cells in culture bind insulin and respond to insulin treatment
[5–7], as is evidenced by increased cell proliferation rates [8,
9], enhanced collagen synthesis [6, 10–12], secretion of bone
formation markers [13], and increased uptake of glucose [14,
15]. In vivo, systemic insulin therapy can prevent or reverse
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skeletaldeficitswhichoccurinrodentmodelsofT1D,includ-
ing improving bone strength and biomechanical integrity
[16–19].Evenlocalinsulindeliverytofracturesitesindiabetic
rodents can ameliorate poor fracture healing which occurs
in T1D [20]. Taken together, these data suggest that insulin
may play a critical role in normal osteoblastogenesis and
that conditions of insulin deficiency may lead to abnormal
skeletogenesis.
A direct link between insulin signaling and bone for-
mation in vivo is supported by transgenic mouse models.
Knockdown of the insulin receptor (IR) in osteoblasts results
in altered bone formation [21] and in abnormal trabecular
architecture [22]. These studies support a role for insulin in
matureosteoblasts;Ferronetal.[21]reporta60%knockdown
of the Insr using the Col1a1-Cre mouse, while Fulzele et al.
[22]h a v ee l i m i n a t e dt h eInsr in mature osteoblasts using the
osteocalcin- (OC-) Cre construct.
Toexaminefurtherthespecificactionofinsulinsignaling
on bone, we generated mice lacking the insulin receptor in
osteoprogenitor cells. Unlike previous reports that deleted
IR in mature osteoblasts, [21, 22] we assessed the effect of
IR deletion at the early stages of osteoblast differentiation
(osterix) on the architectural, structural, and biomechanical
properties of bone. We hypothesized that the ablation of
insulin signaling prenatally in cells of the osteoblast lineage
via a loss of IR would impair the fracture resistance of mouse
bones, independent of body size.
2. Materials and Study Design
2.1. Ethics Statement. This research protocol was approved
by the Institutional Animal Care and Use Committee of the
University of Arkansas for Medical Sciences.
2.2. OIRKO Mice. Our experimental objective was to gen-
erate mice lacking the insulin receptor in osteoblast lineage
cells considered as precursors to previously reported models
(i.e., Col1a1-Cre or osteocalcin- (OC-) Cre). Therefore, to
generate mice with an osteoprogenitor-selective ablation of
the insulin receptor (OIRKO), we first crossed mice that
were homozygous for a floxed insulin receptor (IR) allele
in which loxP sites flank exon 4 of the IR gene (designated
IR
lox/lox)[23]withheterozygousosterix-(Osx-)Cretransgenic
mice (B6.Cg-Tg(Sp7-tTA,tetO-EGFP/cre)1Amc/J; The Jack-
son Laboratory, Bar Harbor, ME). F1 progeny were crossed
to produce IR
lox/lox/Cre
+/−(OIRKO) and IR
lox/lox/Cre
−/− mice
which were then bred to produce experimental animals. The
IR
lox/lox/Cre
−/− mouse (IR flox) was designated as the control
for this study, in keeping with previous reports [21, 22]. Cre
transgene expression is repressed when mice receive chow
containing doxycycline (Diet S3888, Bio-Serv, Frenchtown,
NJ). Upon switching mice to a regular chow diet (Diet 8640,
Harlan, Indianapolis, IN) the Cre transgene is expressed in
the osteoblast lineage, resulting in disruption of the floxed
IR alleles in the osteoblast lineage. In this study, pregnant
females were switched to regular chow approximately 1 week
prior to birth of experimental pups. Nursing dams were
maintained on regular chow and experimental mice were
weaned to a regular chow diet. Genotyping was performed
using published procedures [23].
Postnatal growth, as assessed by weight gain, was moni-
tored in both male (𝑛=1 5 ;I Rfl o x( 6 )+O I R K O( 9 ) )a n d
female (𝑛=1 5 ;I Rfl o x( 6 )+O I R K O( 9 ) )m i c ea t4 ,6 ,8 ,a n d
10–12 weeks of age (Figure 1).Detailedmetabolicandskeletal
a s s e s s m e n t sw e r et h e nc o m p l e t e d .
2.3. Metabolic Assessment. Between 10-11 weeks of age in
malesand12-13weeksofageinfemales,a150-minuteglucose
tolerance test (GTT) was performed. Following an overnight
fast,bloodglucosemeasurementswereobtainedfromallani-
mals before intraperitoneal injection of a 2g/kg body weight
glucose bolus. Blood glucose levels were then measured at
15, 30, 45, 60, and 150 minutes following the glucose bolus.
In males only, insulin levels were also measured at 0, 15,
30, 45, 60, and 150 minutes. Blood glucose was measured
viaglucometer(OneTouchUltra2BloodGlucoseMonitoring
System,Lifescan,Inc.,Milpitas,CA;averageintra-assaycoef-
ficient of variation of 1.7% across a range of 40–300mg/dL
target glucose concentrations). Serum insulin levels were
measured using a mouse insulin ultrasensitive ELISA (80-
INSMSU-E01;ALPCOImmunoassays,SalemNH;sensitivity,
0.115ng/mL, intra-assay coefficient of variation, 6.3%, inter-
assay coefficient of variation, 10.61%). Glucose (males and
females) and insulin (males only) area-under-curve (AUC),
an integrated measure of glucose tolerance, was determined
using GraphPad PRISM software (version 5.02). Serum
total osteocalcin (OC) was measured using the MILLIPLEX
MAP Mouse Osteocalcin-Single Plex assay (MBN-41K-10C,
Millipore Corp., Billerica MA; sensitivity, 8.7pg/mL, intra-
assay coefficient of variation, 11.2%, inter-assay coefficient of
variation, 7.5%). Serum amino-terminal propeptide of type 1
procollagen(PINP)wasmeasuredusingtheRat/MousePINP
EIA (AC-33F1, Immunodiagnostics Systems, Ltd., Fountain
Hills, AZ; sensitivity, 0.7ng/mL). Serum c-terminal telopep-
tide of type 1 collagen, a marker of bone resorption, was mea-
suredusingtheRatLAPsELISA(AC-06F1,Immunodiagnos-
ticsSystems,Inc.,Scottsdale,AZ;sensitivity,1.7ng/mL,intra-
assay coefficient of variation, 5.8%, inter-assay coefficient of
variation, 10.4%).
2.4. Skeletal Assessment. After euthanasia (males: ∼10-11
weeks; females: ∼12-13 weeks), the left tibia and femur were
harvested from IR flox (6 male and 6 female) and OIRKO
(9 male and 9 female) littermates and stored in phosphate
buffered saline (PBS) at −20
∘C until assessment. H & E stain-
ing of the tibial growth plate was performed as previously
described [24]. Femur length was measured using calipers.
Femurs were immersed in PBS at room temperature and the
long axis of the bone was aligned with the scanning axis
of the 𝜇CT40 (Scanco Medical, Br¨ uttisellen, Switzerland).
All scans were acquired with an isotropic voxel size of
12𝜇m using the same energy settings (70kVp/0.114mA),
acquisition parameters (integration time of 300ms with 1000
projections per full rotation), and calibration to a hydrox-
yapatite (HA) phantom with a beam hardening correction
from Scanco Medical, as we have previously described [25].Journal of Diabetes Research 3
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Figure 1: OIRKO mice are smaller in size, with slighter bones. PCR of the IR locus revealed that recombination of floxed IR alleles occurs
onlyinbone((a),ΔIR;calvaria,tibia).OIRKOmiceexhibitedan∼80%decr easeinIRinwho lebo neb yW es t ernb lo t(𝑛=3IRflox,3OIRKO
tibiae, (b)). Loss of the insulin receptor in osteoblasts reduced the size of male and female mice. Postnatal growth curves for male ((c), top)
and female ((c), bottom) IR flox and OIRKO mice are shown (
∗𝑃 < 0.05,
∗∗𝑃 < 0.01,a n d
∗∗∗𝑃 < 0.001). Disruption in the growth plate was
n o ta p p a r e n t( ar e p r e s e n t a t i v eH&Es t a i ni ss h o w n ,( d ) ) .𝜇CT images of the femur midshaft demonstrated that femurs from OIRKO mice
are narrower than from comparably aged IR flox mice (e).
The regions of interest (ROI) included the trabecular bone
of the metaphysis (0.24–1.40mm above the growth plate)
and the cortical bone of the midshaft (1.19mm in length
spanning the midpoint between the condyles and femoral
neck). Each ROI had a unique threshold (406mgHA/cm
3
and 774mgHA/cm
3 for trabecular and cortical bone, resp.)
and Gaussian noise filter (sigma of 0.2 with support of 2
f o rt r a b e c u l a rb o n ea n ds i g m ao f0 . 8w i t hs u p p o r to f2
for cortical bone) that were used for all scans. Standard
evaluation scripts from the manufacturer were used to deter-
minethearchitecturalandstructuralpropertiesoftrabecular
and cortical bone, respectively (Table 1). Moreover, in the
calculations of tissue mineral density (TMD), partial volume
effects were suppressed by peeling the first voxel from all
surfacesfollowingsegmentationofthebone.Theslenderness
of the femur was calculated as the caliper-derived length of4 Journal of Diabetes Research
Table 1: Selected properties of bone, as determined by 𝜇CT and three-point bending, for males (top) and females (bottom), comparing
control (IR flox) and OIRKO mice.
Property (male) Units IR flox (𝑛=6 ) OIRKO (𝑛=9 ) 𝑃-value
Metaphysis (trabecular bone)
BV/TV % 11.71 ± 0.94 8.95 ± 2.04 0.009
Tb.N mm
−1 5.15 ± 0.33 4.95 ± 0.61 0.47
Tb.Th mm 0.0392 ± 0.002 0.0344 ± 0.002 <0.001
Tb.Sp mm 0.195 ± 0.013 0.206 ± 0.028 0.38
SMI
a — 2.33 ± 0.08 2.61 ± 0.20 0.006
Tb.TMD mgHA/cm
3 901 ± 8 888 ± 17 0.10
Diaphysis (cortical bone)
Ma.V mm
3 1.22 ± 0.12 1.03 ± 0.11 0.005
Ct.Th mm 0.148 ± 0.011 0.124 ± 0.011 0.001
Imin mm
4 0.102 ± 0.007 0.066 ± 0.009 <0.001
Ct.Ar mm
2 0.640 ± 0.033 0.4892 ± 0.044 <0.001
Length mm 13.70 ± 0.35 12.59 ± 0.36 <0.001
Slenderness
b mm/mm
2 20.8 ± 0.7 25.1 ± 2.2 <0.001
Ct.TMD mgHA/cm
3 1185 ± 27 1176 ± 25 0.49
Stiffness N/mm 40.7 ± 8.5 36.9 ± 12.6 0.57
Modulus GPa 4.2 ± 0.8 6.1 ± 2.6 0.137
Bending strength MPa 147 ± 17 172 ± 36 0.177
Property (female) Units IR flox (𝑛=6 ) OIRKO (𝑛=9 ) 𝑃-value
Metaphysis (trabecular bone)
BV/TV % 4.38 ± 0.92 4.84 ± 1.52 0.52
Tb.N mm
−1 3.37 ± 0.33 3.35 ± 0.59 0.95
Tb.Th mm 0.037 ± 0.002 0.036 ± 0.004 0.53
Tb.Sp mm 0.302 ± 0.032 0.316 ± 0.084 0.69
SMI
a — 3.19 ± 0.17 2.80 ± 0.18 0.001
Tb.TMD mgHA/cm
3 916 ± 13 901 ± 30 0.28
Diaphysis (cortical bone)
Ma.V mm
3 1.07 ± 0.07 1.01 ± 0.08 0.16
Ct.Th mm 0.162 ± 0.005 0.138 ± 0.011 <0.001
Imin mm
4 0.093 ± 0.010 0.072 ± 0.007 <0.001
Ct.Ar mm
2 0.651 ± 0.028 0.538 ± 0.048 <0.001
Length mm 14.41 ± 0.39 13.22 ± 0.45 <0.001
Slenderness
b mm/mm
2 21.3 ± 0.687 23.5 ± 1.236 0.002
Ct.TMD mgHA/cm
3 1251 ± 15 1209 ± 13 <0.001
Stiffness N/mm 80.6 ± 11.5 57.3 ± 6.7 <0.001
Modulus GPa 9.4 ± 1.5 8.5 ± 1.2 0.26
Bending strength MPa 166 ± 10 161 ± 13 0.50
aStructuralmodelindexcharacterizestheshapeoftrabecularbone(1:platelike;3:rodlike).
bSlendernessistheratioofthelengthtothetotalcross-sectionalarea
ofthefemurmidshaft.Abbreviations:BV/TV:bonevolume/tissuevolume;Tb.N:trabecularnumber;Tb.Th:trabecularthickness;Tb.Sp:trabecularseparation;
SMI: structural model index; Tb.TMD: trabecular tissue mineral density; Ma.V: marrow volume; Ct.Th.: cortical thickness; Imin: moment of inertia; Ct.Ar:
cortical area; Ct.TMD: cortical tissue mineral density. Significant differences are highlighted in bold font.
t h eb o n ed i v i d e db yt h e𝜇CT-derived total cross-sectional
area of the midshaft (i.e., average cross-sectional area includ-
ing medullary canal).
2.5. Biochemical/Molecular Testing. Tissues were harvested
from animals and immediately frozen in liquid nitrogen.
Approximately 20 milligrams of tissue was digested at 58
∘C
overnight in 200𝜇L of buffer (50mM Tris-HCl, pH 8.0,
0.5% Triton X-100) containing Proteinase K (1mg/mL). One
microliter of digested tissue was used in PCR reactions.
Recombination of the floxed insulin receptor allele was eval-
uated by the polymerase chain reaction using the following
primer pairs that amplify exons 3–5: 5
򸀠-GATGTGCACCCC-
ATGTCTG-3
򸀠,5
򸀠-CTGAATAGCTGAGACCACAG-3
򸀠,a n d
5
򸀠-ACGCCTACACATCACATGC-3
򸀠. PCR reactions were
h o ts t a r t i n ga t9 5
∘C for 15 minutes followed by 35 cycles
of 94
∘C for 45 seconds, 60
∘Cf o r1m i n u t e ,a n d7 2
∘Cf o r1
minute, with a final extension step of 72
∘Cf o r5m i n u t e s .Journal of Diabetes Research 5
All reactions were performed on an MJ Research PTC-200
thermal cycler. Western blots were performed with anti-
bodies directed against insulin receptor, beta subunit (Santa
Cruz Biotechnology, Dallas, TX, catalog sc-711, 1:200), and
GAPDH (EMD Millipore, Billerica, MA, catalog MAB374,
1:10,000) as described [26].
2.6. Biomechanical Testing. To determine the differences in
strength between OIRKO and IR flox mice, a preload (1N)
held each hydrated femur in place on the lower support
points of a three-point bending fixture with the anterior
side down (i.e., bending about the medial-lateral plane).
The span between the lower supports was 8mm, and the
load rate was 3.0mm/min. Then, forces from a 100N load
cell (Honeywell, Morristown, NJ) and displacements from
the LVDT (Dynamight 8841, Instron, Canton, OH) were
recorded at 50Hz during a monotonic load-to-failure test.
Measured differences in biomechanical properties included
stiffness and the peak force endured by the bone. Material
properties of modulus and strength of the cortex were also
estimated using standard beam theory [27]. The 𝜇CT scans
p r o v i d e dt h em o m e n to fi n e r t i aa n dt h ed i s t a n c eb e t w e e n
the neutral axis of bending and the outermost point in the
anterior-posterior direction (𝐶min).
To ascertain if any skeletal differences in the OIRKO
mice could be attributed to the presence of the Cre trans-
gene alone, 𝜇CT and three-point bending were also carried
o u ti n8 - w e e k - o l dm a l em i c et h a tw e r eCre
−/− or Cre
+/−
(Supplemental Table 1 in Supplementary Material available
online at http://dx.doi.org/10.1155/2014/703589)o naw i l d -
type background. (These mice were generated from breeding
of IR
+/+/Osx-Cre
−/− and IR
+/+/Osx-Cre
+/− animals.)
2.7. Statistical Analysis. Statistically significant differences
between groups (i.e., IR flox versus OIRKO) within each
gender were detected using the unpaired Student’s t-test.
Data are reported as the mean ± the standard deviation (SD)
unless otherwise specified, and differences were considered
statistically significant at 𝑃 < 0.05.
3. Results
Prenatal elimination of the IR did not appear to affect
fetal survival; OIRKO mice and IR flox control mice were
born with the expected Mendelian frequencies. PCR of the
IR locus indicated that recombination of floxed IR alleles
(ΔIR) occurred only in bone (Figure 1(a); calvaria, tibia).
Assessments of the efficiency and specificity of the IR knock-
out revealed an ∼80% decrease (range: 44–97%) in IR in
w h o l eb o n eb yW e s t e r nb l o t( Figure 1(b)). Both male and
female OIRKO mice appeared grossly normal; however, both
male and female OIRKO mice displayed a postnatal growth
constriction, evident by significant reductions in weight
gain (Figure 1(c)) and by shorter femur length (Table 1).
This occurred despite normally appearing growth plates
(Figure 1(d)). Micro-CT images of the femur midshaft also
demonstrated that femurs from OIRKO mice were narrower
than those from IR flox mice (Figure 1(e)).
Not surprising given their overall size reduction, OIRKO
mice demonstrated a striking skeletal phenotype, but in a
notably gender-specific manner. For male mice, the loss of
IR in osteoprogenitors resulted in a lower trabecular bone
volumefraction(BV/TV)withthinner(Tb.Th),morerodlike
trabeculae in the femur metaphysis (Table 1). In contrast, for
female OIRKO mice, trabecular bone was largely unaffected,
with less rodlike trabeculae. In the diaphyseal compartment,
however, the cortices of femurs from both male and female
OIRKO mice were thinner and exhibited lower structural
parameters (e.g., bone cross-sectional area or Ct.Ar) com-
pared with the cortices from IR flox mice. With a smaller
moment of inertia (𝐼min, Table 1), loss of IR in osteoblasts
caused a decrease in the structural strength of the femur
in bending, compared with IR flox bones (Figure 2:p e a k
force).Adecreaseincorticaltissuemineraldensity(Ct.TMD,
Table 1)wasalsoseeninfemaleOIRKOmice.However,there
was no difference in the estimated bending strength between
genotypes.
As determined by the ratio of bone length to total cross-
sectional area (Tt.AR), the femur slenderness for OIRKO
mice was considerably greater than the femur slenderness
for IR flox bones. This structural impairment in the OIRKO
mice was decoupled from body weight, because the ratio
of slenderness to body weight (Length/Tt.AR per BW) was
higher for knockout than for control mice of both genders
(Figures2(a)and2(b)).Thatis,bonesfromOIRKOmicewere
more slender (i.e., more susceptible to failure) than expected
for their reduced body weight.
While Cre expression alone in the (Osx)-Cre
+/− male
m o u s eh a sb e e ns h o w ni no n es t u d yt on e g a t i v e l ya ff e c t
weight at 4 weeks of age, the effect of Cre was not evident
by 12 weeks of age [28]. We also observed no differences in
weightbetween(Osx)-Cre
−/− and(Osx)-Cre
+/− malemiceat8
weeksofage(SupplementalTable 1).Moreover,thoseskeletal
parameters that were significantly affected in the OIRKO
phenotype (Table 1) were not significantly different between
Cre
−/− and Cre
+/− genotypes, suggesting that the skeletal
phenotype observed in male and female OIRKO mice is
accounted for principally through the diminished expression
of the IR.
Because insulin signaling in bone has been linked by
others to a feed-forward mechanism to activate osteocalcin,
which in turn regulates glucose homeostasis [21, 22], we
also examined the metabolic phenotype of the OIRKO mice
(Table 2). In this model, there were no significant abnormal-
ities in fasting blood glucose or insulin levels or in glucose
or insulin dynamics after a glucose challenge (Table 2)i n
O I R K Om i c ec o m p a r e dw i t hI Rfl o xm i c e .M o r e o v e r ,t o t a l
o s t e o c a l c i nl e v e l sw e r en o ts i g n i fi c a n t l yd i ff e r e n tb e t w e e n
groups in either male or female mice. While undercarboxy-
lated osteocalcin has been reported to be lower in mice
in which the IR has been eliminated in mature osteoblasts
[21, 22], this was not measured in our study due to the
lack of a validated and commercially available assay for
undercarboxylated osteocalcin in mice.
Osteoclast activity was assessed by examining systemic
concentrations of c-terminal telopeptide of type 1 collagen6 Journal of Diabetes Research
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Figure 2: OIRKO femurs are weaker and more slender. Loss of IR in osteoblasts caused the bone to be more slender (ratio of length to total
cross-sectional area) relative to body weight (Length/Tt.AR per BW; (a), male; (b), female). Loss of IR in osteoblasts also caused a decrease
in the structural strength of the femur in bending (peak force; (c), male; (d), female). Data is displayed as a scatter-plot, with mean and SEM
indicated.
Table 2: Metabolic phenotype of males (top) and females (bottom), comparing control (IR flox) and OIRKO mice.
Units IR flox (𝑛=6 ) OIRKO (𝑛=9 ) 𝑃 value
Measurements (male)
Final body weight g 24.7 ± 2.2 19.3 ± 2.0 <0.001
Fasting insulin ng/mL 0.14 ± 0.04 0.26 ± 0.22 0.24
Fasting blood glucose mg/dL 67.8 ± 11.4 68.11 ± 11.4 0.97
Insulin AUC — 43.8 ± 17.0 40.5 ± 8.9 0.63
Glucose AUC — 46,660 ± 10,660 43,450 ± 10,328 0.57
OC ng/mL 109.6 ± 9.7 99.5 ± 38.7 0.54
RatLAPS ng/mL 25.1 ± 2.3 21.3 ± 3.8 0.05
Measurements (female)
Final body weight g 23.1 ± 2.6 17.6 ± 2.4 0.001
Fasting blood glucose mg/dL 52.7 ± 7.6 52.6 ± 11.6 0.98
Glucose AUC — 27,781 ± 3985 30,695 ± 5300 0.27
OC ng/mL 120.7 ± 38.1 92.5 ± 35.0 0.16
RatLAPS ng/mL 25.5 ± 5.1 23.8 ± 7.6
a 0.64
Abbreviations: AUC: Area under the curve; OC: osteocalcin; RatLAPS; a marker of bone resorption.
a𝑛=8for this measurement. Significant differences are
highlighted in bold font.Journal of Diabetes Research 7
(i.e., RatLAPS).C-terminaltelopeptideof type 1 collagen was
modestly lower in male OIRKO mice (Table 2), compared
with IR flox mice, but not different when genders were
combined (𝑃 = 0.15). Osteogenesis was further assessed by
measuring systemic concentrations of PINP; these concen-
trations were not different between OIRKO mice and IR flox
mice (𝑃 = 0.97).
4. Discussion
Elimination of the insulin receptor specifically in osteopro-
g e n i t o rc e l l sa ff o r d st h eo p p o r t u n i t yt os t u d yt h ei m p a c to f
the IR and its ligand in vivo on bone development, without
the metabolic consequences associated with eliminating the
IR in all tissues, which consistently leads to hyperinsu-
linemia. OIRKO mice also provide a model of osteoblast-
specific decreased insulin action, as expected in patients
with suboptimally controlled T1D, but without concurrent
hyperglycemia. As such, loss of IR in the osteoblast lineage
resulted in a growth-constricted phenotype. Although the
femur length, indicative of appendicular bone growth, was
r ed ucedinth eO IRK O ,th ethic knes so fth edia p h ysealco rt ex
was more greatly affected, resulting in a more slender femur
which manifested a decrease in the structural strength. In
male mice alone, decreased metaphyseal trabecular bone,
with thinnerand morerodliketrabeculae, was also observed.
Moreover, the skeletal phenotype of the OIRKO mouse
appears more severe than that reported using the Col1a1-
Cre or the OC-Cre construct [21, 22], suggesting that earlier
elimination of the IR in osteoblast development may provide
further insights into its overall role in osteoblastogenesis.
The reduced body size of both male and female OIRKO
mice was evident as early as at 4 weeks of age and persisted
throughoutthisstudy.By10–12weeksofage,amicroarchitec-
tural skeletal phenotype was clearly evident. It remains to be
seen how elimination of IR in this model will impact skeletal
integrity,bonestrength,andbonehealingasOIRKOmiceage
further,thoughmoreprofounddeficitsmaybecomeapparent
in older mice. Studies are ongoing to address this question.
In mice made insulin deficient, insulin treatment can
restore trabecular architecture, suggesting that insulin may
be involved in trabecular homeostasis [19]. Fulzele et al. have
shown that lack of insulin receptor signaling in osteoblasts
alters trabecular acquisition as evidenced by decreased
BV/TV, Tb.N, and Tb.Th and increased Tb.Sp in young
male mice (3–6 weeks of age) lacking IR expression in
mature osteoblasts [22]. However, these differences appear to
dissipate as the mice age [22]. In the current study, BV/TV
and Tb.Th were decreased in male OIRKO mice, consistent
with the previous findings by Fulzele et al. [22]; however,
we did not study older OIRKO mice to see if the trabecular
phenotype persists. Indeed, in slightly older female OIRKO
mice, no major differences were noted in the trabecular
compartment; however, these differences between OIRKO
male and female mice might not simply be attributable to
age but may reflect the impact of gender, as estrogen has a
protective effect on metaphyseal bone [29].
As in previous studies investigating osteoblast-specific
deletion of IR in male mice [21, 22], we too observed a
modestreductioninaserummarkerofboneresorptioninthe
male OIRKO mouse (but not in the female OIRKO mouse).
Nevertheless, decreased resorption in male OIRKO mice did
nottranslateintoelevatedglucoselevelsorchangesininsulin
dynamicsintheOIRKOmodel.Thislackofglucoseorinsulin
dysregulation varies from the observations of others in male
mice, wherein IR expression in osteoblasts was reduced
using OC-Cre and Col1a1-Cre [21, 22]. It was anticipated that
eliminating the IR in osteoprogenitors rather than in more
ma t ur eosteoblastsmigh tca usea nevenmo r ep r o f o undeff ect
on glucose homeostasis, more consistent with frank diabetes.
However, within each gender of OIRKO mice, no significant
differences in glucose tolerance were seen, suggesting a
more complex connection between osteoblasts and energy
metabolism than previously appreciated. Additionally, total
o s t e o c a l c i nl e v e l sw e r en o ts i g n i fi c a n t l yd i ff e r e n tb e t w e e n
IR flox and OIRKO mice. Total osteocalcin levels have
been reported to be suppressed in male mice in which the
I Rw a se l i m i n a t e df r o mm a t u r eo s t e o b l a s t su s i n gt h eOC-
Cre construct, yet when the IR in osteoblasts is eliminated
using the Col1a1-Cre, no difference in osteocalcin levels was
observed [21, 22], similarly to the OIRKO mouse.
At present, little is known about the specific mecha-
n i s m su n d e r l y i n gd i a b e t i cb o n ed i s e a s e .W h i l et h ec u r r e n t
s t u d yd o e sn o ty e te l u c i d a t em e c h a n i s t i cp a t h w a y sb yw h i c h
insulin signaling is critical to osteoblastogenesis, we can
infer that insulin receptor expression in osteoblasts is quite
important for proper bone development and maintenance
of structural integrity. Further mechanistic analysis of the
OIRKO genotype in future studies will be necessary to
explain the observed phenotype, and studies using these
geneticallymodifiedmiceshouldbroadenourunderstanding
of diabetic bone disease. From the present studies, however,
we hypothesize that, in T1D, insulin deficiency leading
to long-term decreased insulin receptor signaling in the
growing bones of children and adolescents with this disease
might suppress periosteal bone expansion and alter the bone
microarchitecture, increasing susceptibility to fracture in
lateryears.Validatingthishypothesisinhumansalsorequires
further investigation.
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